Extend your brand profile by curating daily news.

Study Links Electric Vehicle Regenerative Braking to Increased Motion Sickness

By Advos

TL;DR

Rivian Automotive could gain a competitive edge by innovating solutions to reduce motion sickness caused by regenerative braking in electric vehicles.

A 2024 study found that heavier reliance on regenerative braking in electric vehicles produces measurably higher levels of nausea in motion sickness sufferers.

Addressing motion sickness in electric vehicles improves passenger comfort and makes sustainable transportation more accessible to millions of travelers.

Research reveals that the very features making electric cars appealing, like regenerative braking, may unexpectedly worsen motion sickness for passengers.

Found this article helpful?

Share it with your network and spread the knowledge!

Study Links Electric Vehicle Regenerative Braking to Increased Motion Sickness

Electric vehicles may be contributing to increased motion sickness episodes for millions of travelers, according to research published in 2024. The study, which appears in the International Journal of Human-Computer Interaction, suggests that the very features that make electric vehicles environmentally appealing could be worsening a common travel discomfort.

Researchers conducted real-world driving tests with 16 participants known to suffer from motion sickness and discovered a consistent pattern: heavier reliance on regenerative braking produced measurably higher levels of nausea. Regenerative braking, a system that captures energy during deceleration and converts it back to battery power, creates different acceleration patterns than traditional friction braking systems. These subtle differences in vehicle dynamics appear to trigger stronger motion sickness responses in susceptible individuals.

The findings present significant implications for both consumers and the automotive industry. For the estimated millions who experience motion sickness during travel, the transition to electric vehicles could mean more uncomfortable journeys unless manufacturers address this issue. The research suggests that electric vehicle makers who develop innovative solutions to mitigate motion sickness could gain a competitive advantage in the marketplace.

Companies like Rivian Automotive Inc. (NASDAQ: RIVN) and other electric vehicle manufacturers now face the dual challenge of maintaining the efficiency benefits of regenerative braking while minimizing its negative effects on passenger comfort. The study's publication in the International Journal of Human-Computer Interaction provides scientific validation for what some early electric vehicle adopters have reported anecdotally.

This research matters because it highlights an unintended consequence of green transportation technology that could affect widespread adoption. As governments worldwide push for electric vehicle adoption through incentives and regulations, understanding and addressing potential drawbacks becomes increasingly important. The motion sickness issue represents both a public health consideration and a business opportunity for automakers who can engineer solutions that maintain environmental benefits while improving passenger comfort.

The complete study is available through the International Journal of Human-Computer Interaction, and additional information about electric vehicle developments can be found at https://www.GreenCarStocks.com. The research underscores the complex relationship between technological innovation and human physiology, reminding engineers and designers that even environmentally beneficial technologies must account for human factors to achieve widespread acceptance.

blockchain registration record for this content
Advos

Advos

@advos